TIM-3 is upregulated by TGF-β on tumor-associated macrophages (TAMs) of the M2 phenotype and ligation of TIM-3 leads to increased NF-κB and IL-6 production and is associated with reduced survival in human hepatocellular carcinoma (170). Here, NFKB1 is linked to neoplasm.